Evidence map›Paper›PMID 31179855›Full record

ArticleRNA biology2019

Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.

Piyush Joshi, Tatsuya Seki, Shinobu Kitamura, Andrea Bergano, Bongyong Lee, Ranjan J Perera

Abstract read
In one paragraph

Article in RNA biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Metabolic labeling of RNA using ribonucleoside analogs enables the evaluation of RNA synthesis and degradation rates.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Piyush JoshiDepartment of Oncology, Johns Hopkins University School of Medicine , Baltimore , MD , USA.ORCID 0000-0002-5631-336X
Tatsuya SekiSanford Burnham Prebys Medical Discovery Institute , Orlando , FL , USA.
Shinobu KitamuraMedical and Biological Laboratories , Nagoya , Japan.
Andrea BerganoSanford Burnham Prebys Medical Discovery Institute , Orlando , FL , USA.
Bongyong LeeSanford Burnham Prebys Medical Discovery Institute , Orlando , FL , USA.
Ranjan J PereraSanford Burnham Prebys Medical Discovery Institute , Orlando , FL , USA.ORCID 0000-0002-5926-3687

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
Identification of the molecular mechanism of miR-211 and its target genes in melanocytes and pigmented melanoma senescence and apoptosisR21CA202197 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PERERA, RANJAN JOSEPH · 2016 to 2017
$467k
Identification and characterization of long noncoding RNAs in human melanomasR03CA165184 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PERERA, RANJAN JOSEPH · 2012 to 2013
$189k
NCI NIH HHS P30 CA006973NCI NIH HHS P30 CA030199NCI NIH HHS R03 CA165184NCI NIH HHS R21 CA202197
6 · The paper itself

Abstract

RNA half-life is closely related to its cellular physiological function, so stability determinants may have regulatory functions. Micro(mi)RNAs have primarily been studied with respect to post-transcriptional mRNA regulation and target degradation. Here we study the impact of the tumour suppressive melanoma miRNA miR-211 on transcriptome stability and phenotype in the non-pigmented melanoma cell line, A375. Using 5'-bromouridine IP chase (BRIC)-seq, transcriptome-wide RNA stability profiles revealed highly regulated genes and pathways important in this melanoma cell line. By combining BRIC-seq, RNA-seq and

Indexed as

Gene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingRNA InterferenceTranscriptomeCell Line, TumorComputational BiologyDisease ProgressionGene Expression ProfilingGene OntologyHumansMelanomaMicroRNAsMitogen-Activated Protein KinasesNeoplasm StagingPhosphatidylinositol 3-KinasesRNA, MessengerMicroRNAsMitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesRNA, MessengerBRIC-seqmelanomamicroRNARNA-seqRNA stability

Identifiers

PMID31179855
PMCPMC6779404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.